LAS VEGAS, July 14, 2014 (GLOBE NEWSWIRE) -- Hemp, Inc. (OTC:HEMP) is pleased to announce it has issued more than $240,600 in stock dividends to its shareholders last week resulting from the strategic decision to spinoff its non-core company, BioAdaptives, Inc. (OTCBB:BDPT). While having been a fully reporting company for some time now, BioAdaptives, Inc. was just cleared for trading last week which made some pretty "jubilant" Hemp, Inc. shareholders, according to Hemp, Inc.'s CEO, Bruce Perlowin, as it grew to over $9,000,000 within 3 days.
Shareholders owning common stock as of record date January 14, 2014, were collectively issued 2,015,000 shares of BioAdaptives, Inc. common stock as a dividend on April 7, 2014 and should have recently received a book-entry account statement reflecting their ownership of BioAdaptives, Inc. (OTCBB:BDPT) common stock or a credit in their brokerage account with the BioAdaptives, Inc. (OTCBB:BDPT) shares. The value of the stock, at issue, was $.12 per share. However, in the first week of trading, the stock increased by over 3,733% to $4.60 per share. That's an increased value, of issued stock, from $240,600 to $9,223,000.
Bruce Perlowin, CEO of Hemp, Inc. said, "It took longer than we expected to get to this point but it was well worth the wait. The decision to spin off assets, not part of our core company, proved beneficial, as it allows Hemp, Inc. to focus on core business and effectively grow the company for the good of the shareholders." He continued saying, "Current and future shareholders of Hemp, Inc. now have 9,223,000 reasons to buy and hold Hemp, Inc. stock...primary reason being eligible to receive future dividends in the next three company spinoffs."
"It is Hemp, Inc.'s intent to create 'enhanced value' for all of our shareholders and our industry in any and all ways that we can. With the dividend stock of almost $9,500,000 (based on price per share of 4.60 at close of BioAdaptives trading day Friday, July 11th), we've certainly accomplished creating that 'enhanced value' are we are very optimistic that the value of BioAdaptives, Inc. stock will continue to increase in the forthcoming days and weeks," said Bruce Perlowin, CEO of Hemp, Inc. (OTC:HEMP).
While separated from BioAdaptives, Inc., Hemp, Inc. continues to trade "regular way" under its symbol (HEMP) and retains no ownership interest, at this time, in BioAdaptives, Inc. Perlowin also expressed Hemp, Inc. will be issuing more dividends from its other spin offs, with VOIPNetX being next.
"Considering the fact we have been working on 3 other companies, each with dividend shares to be distributed, we have certainly created 'enhanced benefits and value' for the loyal shareholders of Hemp, Inc. today and in the future. The public will be notified of the ex-dividend dates, of each of the forthcoming spinoffs, as they approach, in future press releases."
Hemp, Inc. executives also commented on their appreciation of all the emails and phone calls the company has received from shareholders and added, "We are very excited about the possibility of BioAdaptives, Inc. shares making the dividend even more valuable as the days and weeks go by."
The nutraceutical research and development company (BioAdaptives, Inc.) is a development stage company building "a base of intellectual property and products that are patent-pending and in demand in today's marketplace." The BioAdaptives, Inc.'s nutraceuticals are designed to "increase circulating stem cells, aid in cognition, focus, fatigue reduction, increased testosterone, improved overall emotional and physical wellness, healing, and anti-aging."
ABOUT HEMP, INC.
Hemp, Inc. (OTC:HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (OTC:HEMP) is not currently involved in the cultivation or marketing of medical cannabis. (www.hempinc.com) Watch Bruce Perlowin on Bloomberg TV.
ABOUT THE INDUSTRIAL HEMP AND MEDICAL MARIJUANA CONSULTING COMPANY, INC.
The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. (OTC:HEMP) that pulls industry information from a vast network of specialists. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. (www.HempInc.com) Executives of IHMMCC are interviewing an additional 14 companies and expect considerably more to sign up with this network of companies in the coming weeks, and months.
According to Perlowin, the future is also very bright for Hemp, Inc.'s subsidiary, The Industrial Hemp and Medical Marijuana Consulting Company, known as IHMMCC which is comprised of a "Community of Companies". IHMMCC has been touted as the best 'connected' consulting company in the industry. Thus far, the public companies include: Dewmar International BMC, Inc. (OTC:DEWM); Resource Ventures, Inc. (OTC:REVI); Webxu, Inc. (OTC:WBXU); Greene Concepts, Inc. (OTC:LKEN); Global Links Corp (OTC:GLCO); Strategic Global Investments, Inc. (OTC:STBV); Liberated Energy, Inc. (OTC:LIBE); Hollund Industrial Marine, Inc. (OTC:HIMR); Vapor Brands International, Inc. (OTC:VAPR); Cloud Medical Doctor Software Corp (OTC:NSCT); View Systems, Inc.; and, PPJ Enterprise (OTC:PPJE), which have all mutually benefitted from the network.
HEMP, INC.'s TRIPLE BOTTOM LINE
Hemp, Inc. (HEMP) seeks to benefit many constituencies, not exploit or endanger any group of them. Thus, the publicly-traded company believes in "up-streaming" of a portion of profit from the marketing of their finished hemp goods back to its originator. By Hemp, Inc. focusing on comprehensive investment results—that is, with respect to performance along the interrelated dimensions of people, planet, and profits— our triple bottom line approach can be an important tool to support sustainability goals.
SAFE HARBOR ACT
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.